In this first part of a video interview series, Abby Kim, Pharm.D., of Prime Therapeutics shows how advances such as precision medicine and CAR T therapy are improving outcomes while requiring managed care leaders to rethink value through a long-term lens of cost, toxicity and patient access.
A talk by presidential historian Jon Meacham kicked off the official beginning of the meeting at the Music City Center in Nashville, Tennessee.
A multinational study found that metformin use was associated with significantly lower odds of esophageal squamous cell carcinoma, supporting further research into its potential role in cancer prevention and treatment.
A single-arm Japanese trial found that pazopanib did not improve progression-free survival but demonstrated encouraging response rates and overall survival in patients previously treated with paclitaxel.
A study in Translational Psychiatry found that adding rTMS to standard care may quickly improve flu-related sleep issues by targeting brain activity and immune responses linked to insomnia.
Adults in rural Appalachian Kentucky are facing a severe sleep crisis when compared to the rest of the country, a trend exacerbated by income inequality
The 2026 MHE Pharmacy Survey asked questions about most-favored nation drug pricing, PBM reform and HHS Secretary Robert F. Kennedy Jr.'s vaccine policies. Respondents rated direct-to-consumer drug sales by drugmaker as the most important development in the pharmaceutical sector this year.
New data from the Health Care Cost Institute shows that higher hospital prices and limited competition, not greater use of care, are the main reasons healthcare spending varies widely across U.S. metro areas.
Per- and polyfluoroalkyl substances seem to be associated with a high risk of reduced fertility, as well as maternal health concerns such as preeclampsia and gestational diabetes.
Lack of federal legislation and consolidation of hospitals into large health systems are among the reasons states are getting more involved in healthcare regulation and oversight.
The former chief health officer for Oracle sees artificial intelligence as the way to incorporate the many nonclinical factors that affect health into healthcare.
A convergence of legislative and judicial actions is creating PBM transparency, adding fiduciary responsibility, and addressing anti-competitive behavior, participants Jeffrey Hogan and Chad Worz, Pharm.D., said during a webinar sponsored by Managed Healthcare Executive and Drug Topics.
A new study found a specific brain and spinal cord circuit that appears to cause chronic pain after injury and could one day be targeted to treat pain without affecting the body's normal protective pain responses.
The pill version of Wegovy was available in January after the FDA approved it in December 2025. Eli Lillyʼs competitor, Foundayo (orforglipron) was approved by the FDA on April 1.
Nearly all U.S. adolescents who are at risk for HIV are missing out on preexposure prophylaxis, with significant disparities in access based on age, gender and geographic location.
Additionally, Orlando Health — Health Central Hospital is building a new cardiac catheterization laboratory with specialized electrophysiology equipment.
The FDA has approved two drugs for treatment of the condition, Rezdiffra (resmetirom) and Wegovy (semaglutide), the weight loss drug.
PBMs have launched clinical programs pairing GLP-1 prescriptions with pharmacist coaching, nutrition support, behavioral health partnerships, and digital tools to improve adherence and outcomes.
CMS boosts Medicare Advantage 2027 rates by 2.48%; Michael Lutz and Ceci Connolly warn MA plans still face inflation and risk-adjustment inequities.
The investigators applied a multinomial statistical model to evaluate associations between individual CT features and final radiologic diagnoses.
A review of clinical trials and genetic, immune, and environmental factors revealed that Asian patients with advanced HER2-negative gastric cancer generally experience higher response rates and longer survival with immunotherapy than non-Asian patients.
A March 2026 study found that U.S. cancer patients with hypertension, hyperlipidemia or diabetes face consistently higher healthcare costs, which increased steadily from 2012 to 2018, dropped during the COVID-19 pandemic and remain elevated compared with patients without these conditions.
New research suggests that when adolescents sleep, not just how long, may play a significant role in shaping their eating habits and activity levels, particularly during the school year.
A new meta-analysis of prospective studies finds artificial intelligence performs similarly to dermatologists in melanoma detection, although more rigorous research is needed before it can be considered as a reliable decision-support tool in routine care.
The California insurer is continuing the program, called Virtual Blue, but also looking to add more virtual care into its standard offerings.
Yuvezzi treats presbyopia, or blurry vision due to aging, and is available at retail pharmacies or PHIL, an ePharmacy platform.
One year after FDA approval, Journavx (suzetrigine) offers a promising non-opioid option for acute pain, but experts have concerns about long-term safety, opioid-sparing effects and real-world use.
Lenox Hill Hospital’s controversial $2 billion redevelopment includes a new mental health clinic, a shorter tower, and expanded emergency, surgical, and maternity facilities.
Dermatology performance measures need to be streamlined and redesigned to better capture meaningful patient outcomes while reducing administrative burden and aligning with value-based care.
The two oral GLP-1s will battle for market share. Foundayo is a small-molecule drug that can be taken with food. Some data suggest that oral Wegovy is slightly better at producing weight loss.
